Paper Details

  1. Home
  2. Paper Details

Economic evaluation of screening for prostate cancer: a randomized population based programme during a 10-year period in Sweden.

Author: CarlssonP, HolmbergH, LöfmanO, VarenhorstE

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Prostate cancer screening is becoming more common, but its overall impact on survival is not clear. This study evaluated the costs and benefits of screening for prostate cancer in a Swedish community. The study found that screening would increase healthcare costs by about 179 million SEK per year, with an additional cost of 158,000 SEK for each new case of localized cancer detected. While screening could identify more localized cancers, the long-term effects on quality of life and death rates are unknown.
Paper Details　
Original Abstract of the Article :
Prostate cancer is a growing health problem representing considerable costs. Screening and early curative treatment may reduce morbidity and possibly prevent future escalating costs. However, population screening programmes are generally not well accepted at present due to uncertainty about whether ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/s0168-8510(98)00037-2

データ提供：米国国立医学図書館（NLM）

The Economics of Prostate Cancer Screening: A Desert of Choices

The vast desert of healthcare economics presents a multitude of challenges, requiring careful navigation and informed decision-making. This study, like a meticulous cost-benefit analysis, examines the economic implications of prostate cancer screening, a critical public health concern.

The Cost of Early Detection

The researchers, like astute desert traders, carefully calculated the costs and benefits of a population-based prostate cancer screening program. Their findings revealed that screening, while potentially increasing the detection of localized cancer, also led to higher healthcare costs. This study emphasizes the need for a nuanced understanding of the economic implications of screening programs, considering factors like false positives and overdiagnosis.

Balancing Costs and Benefits

The desert of healthcare decision-making often requires striking a balance between costs and benefits. This study serves as a reminder that while early detection can be beneficial, it’s essential to consider the potential economic impact and ensure that screening programs are cost-effective and aligned with overall healthcare priorities. The researchers’ findings provide valuable insights for policymakers and healthcare providers as they navigate this complex terrain.

Dr. Camel’s Conclusion

This study underscores the importance of evidence-based decision-making in healthcare. It’s a reminder that the desert of economics, like the desert itself, is a complex and ever-changing landscape. As we continue to explore the balance between costs and benefits, we must remain committed to ensuring that our healthcare resources are utilized wisely and effectively.
Date :
  1. Date Completed 1998-12-04
  2. Date Revised 2019-12-10
Further Info :

Pubmed ID

10186224

DOI: Digital Object Identifier

10.1016/s0168-8510(98)00037-2

Related Literature

Article Analysis
・Effective treatment of prostate cancer screening
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.